Arrow Positive Placement Con/Epidural an
510(k) K801912
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK801912 | Date16 Sep 1980 | StatusActive |
Recalls
-
- Ongoing Z-2364-2026
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
-
- Terminated Z-2803-2020
The lidstock states the incorrect expiration date for the product. This issue could result in use of a device that is expired which could potentially lead to an increased risk of infection or other complications. Sterility, biocompatibility, safety, or efficacy of the kits and their components are not assured beyond the correct expiration date.
-
- Terminated Z-1175-2020
There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
-
- Terminated Z-1249-2020
- Terminated Z-1251-2020
- Terminated Z-1246-2020
- Terminated Z-1248-2020
- Terminated Z-1247-2020
- Terminated Z-1245-2020
Product lidstock contains the incorrect expiration date for the product
-
- Terminated Z-2012-2018
Product sterility may be compromised due to unsealed packaging.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CAZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.5140
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent